Skip to content

Mutation of the LEPR Gene at Reunion Island: Involvement in Pediatric Obesity

Mutation of the LEPR Gene at Reunion Island: Involvement in Pediatric Obesity GRÉOL (Génétique Réunion Obésité LEPR)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04329260
Acronym
GREOL
Enrollment
250
Registered
2020-04-01
Start date
2021-03-31
Completion date
2022-12-31
Last updated
2021-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Childhood

Brief summary

The objective of this study is to estimate the proportion of the recurrent deletion Δ6-8 of the LEPR gene in the homozygous and heterozygous state in pediatric cases with severe and early ( before the age of 6) obesity (BMI ≥ IOTF-30) on Reunion Island.

Detailed description

The study of the deletion Δ6-8 of the LEPR gene starts with a saliva sample using a swab in children aged between 3 to 18 years old. The DNA from this sample will then be analyzed by the PCR technique. If the deletion of the LEPR gene is confirmed in the patient, his adult family members will also be screened using the same procedure.

Interventions

None listed

Sponsors

Centre Hospitalier Universitaire de la Réunion
Lead SponsorOTHER

Study design

Observational model
FAMILY_BASED
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
3 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* patient with early severe and non syndromic obesity (BMI\> IOTC-30) (before 6 years old) * adult family members with deletion of LEPR gene * informed consent form signed by participants or parents * affiliation to social security scheme

Exclusion criteria

* patient with syndromic obesity * patient Under guardianship or Under judicial protection

Design outcomes

Primary

MeasureTime frameDescription
Proportion of the Δ6-8 deletion of the LEPR gene in paediatric populationat inclusionPresence of the deletion of the LEPR gene

Secondary

MeasureTime frameDescription
Proportion of the Δ6-8 deletion of the LEPR gene in adult family members6 months after inclusion of the paediatric populationPresence of the deletion of the LEPR gene

Contacts

Primary ContactEmilie TECHER
emilie.techer@chu-reunion.fr+262 262 90 62 89

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026